Acclin Path Labs India Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.50 Cr
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 220.36%
- Profit Growth 3456.20%
- Ebitda 2136.73%
- Net Worth 282.14%
- Total Assets 155.66%
About Acclin Path Labs India
Acclin Path Labs India Private Limited (APLIPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 October 2019 (Five years and four months 8 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Tirupathi Bekkam and Joseph Mundra serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100TG2019PTC136291
- Company No.
136291
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Oct 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Healthcare
Who are the key members and board of directors at Acclin Path Labs India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tirupathi Bekkam  | Director | 23-Oct-2019 | Current |
| Joseph Mundra | Director | 23-Oct-2019 | Current |
Financial Performance of Acclin Path Labs India.
Acclin Path Labs India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 220.36% increase. The company also saw a substantial improvement in profitability, with a 3456.2% increase in profit. The company's net worth Soared by an impressive increase of 282.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acclin Path Labs India?
Unlock access to Acclin Path Labs India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Acclin Path Labs India?
Acclin Path Labs India has a workforce of 152 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acclin Path Labs India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acclin Path Labs India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.